Top

Reactions Weekly

Published in:

01-04-2024 | Afatinib | Case report

Afatinib

Skeletal muscule loss

Published in: Reactions Weekly | Issue 1/2024

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Nie X, et al. EP12.01-09 Predictive and Prognostic Value of Early Skeletal Muscle Loss during First-Line EGFR-TKIs for Advanced Lung Adenocarcinoma. Journal of Thoracic Oncology 18 (Suppl.): S643-S644 abstr. EP12.01-09, No. 11, Nov 2023. Available from: URL: https://dx.doi.org/10.1016/j.jtho.2023.09.1224 [abstract]

Title: Afatinib
Skeletal muscule loss
Publication date: 01-04-2024
Publisher: Springer International Publishing
Keyword: Afatinib
Published in: Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-55866-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Afatinib

Skeletal muscule loss

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Antibacterials

Zinc-oxide

Mercaptopurine/Pegaspargase

Paracetamol

Daunorubicin/mitoxantrone/tretinoin

Levothyroxine-sodium